-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on DexCom, Raises Price Target to $82

Benzinga·07/31/2026 17:25:17
语音播报
JP Morgan analyst Robbie Marcus maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $65 to $82.